MPM Capital is a venture capital firm founded in 1996. The firm was founded by Luke Evnin and Ansbert Gadicke. It is primarily based in Cambridge, Massachusetts although it also has offices in Brisbane, California and Kansas City, Kansas. As of March 2019, the firm is managing 33 active companies in its portfolio and has sold off its ownership in 199 companies. Its most recent investment was in Harpoon Therapeutics on November 2018, a company developing clinical-stage immunotherapy .
Funding
MPM Capital specializes in funding life sciences and healthcare companies. It provides financing at various stages of development, from seed to buyout. The firm invests on companies worldwide, but it prioritizes funding companies that are based in the United States, Europe, and India. Since its establishment, the firm has managed to amass a total fund of $2.9 billion across ten funding series. Its most recent funding round was held in February 2019 which collected $400 million.
Timeline
Funded Companies
Cellerant TherapeuticsA biotechnology company that develops treatments for cancer and hematologic conditions
Biotechnology
Stem cell
Immunotherapy
Oncology
Cancer immunotherapy
Therapeutics
Therapy
San Carlos, California
United States
23andMeA biotechnology company based in Mountain View, California providing DNA genetic testing and analysis services.
Genetics
Genealogy
Mountain View, California
TCR2 TherapeuticsTCR2 Therapeutics is a biotechnology company developing T cell hematologic cancer immunotherapies.
Healthcare
Cambridge, Massachusetts
Aryx TherapeuticsA pharmaceutical company developing oral therapies for chronic diseases.
Drug delivery
Fremont, California
NevroNevro is a Menlo Park, California-based biotechnology company.
Menlo Park, California
EndoGastric SolutionsEndoGastric Solutions is a medical device company developing and commercializing innovative, evidence-based, incisionless surgical technology for the treatment of gastroesophageal reflux disease (GERD).
Redmond, Washington
MacroGenicsA biopharmaceutical company developing therapeutics for the treatment of cancer, infectious diseases and autoimmune disorders
Rockville, Maryland
Aratana TherapeuticsA company developing therapeutics for veterinary medicine
Kansas City, Kansas
San Diego
Astute MedicalA life science devices company focused on the discovery and development of protein biomarkers as diagnostic tests
EpizymeA biopharmaceutical company focused on the discovery and development of epigenetic medicines to treat cancer and other disease
Cambridge, Cambridgeshire
Radius HealthA company developing drug therapies for osteoporosis and women’s health
PharmAtheneA biodefense company developing medical countermeasures against threats of biological and chemical weapons
Annapolis, Indiana
Annapolis, Maryland
iPierianA company focused on the discovery and development of therapies for neurodegenerative diseases
South San Francisco, California
AllozyneA company developing technologies in protein-based therapeutics
Pharmaceutical industry
Seattle
Theraclone SciencesA biotechnology company that develops therapeutic antibodies for treating infectious diseases and inflammation
Medicine
VerastemA biopharmaceutical company that develops therapeutics to treat cancer
Boston
TV2 HoldingA company focused on development and manufacture of products for endovascular aortic repair
Santa Rosa, California
Syndax PharmaceuticalsA pharmaceutical company that develops therapies targeting solid and hematological cancer tumors
Waltham, Massachusetts
CymaBay TherapeuticsA company developing treatments for liver and other chronic dieases
Hayward, California
Xanodyne PharmaceuticalsA pharmaceutical company focused developing products for pain management and women’s healthcare
Newport, Kentucky
OxagenA biopharmaceutical company developing small molecule drugs for asthma, chronic allergy and inflammatory conditions
Alnara PharmaceuticalsA company developing oral protein therapeutics to treat metabolic diseases
CeregeneA company developing treatments for Alzheimer’s disease and other neurological diseases
Elixir PharmaceuticalsA company developing pharmaceuticals to treat metabolic disease
Diabetes mellitus
Selexys PharmaceuticalsA company that develops drugs for the treatment of inflammatory and thrombotic diseases
Oklahoma CityAssociated investment funds
People
Ansbert Gadicke
Co-Founder/Managing Director
Lauren Cauley
Chief Financial Officer
Luke Evnin
Co-Founder/Managing Director
Sarah Reed
Chief Operating Officer
Todd Foley
Managing Director
Further reading
Auto-extract from URL...
Documentaries, videos and podcasts
Auto-extract from URL...
Companies
Chiasma
DigiTix Partners
Entrada
Naked Biome
Rhythm
Syndax
References
MPM Capital
CompanyCompany attributes
Venture capitalCategories
Related Topics
Contributors
- 1
Khadidiatou Amirou
A knowledge enthusiast. - 2
Dawson Sewell
Seeking to explain science and technology through simple writing. - 3
Jordan Safer
Avid runner, book reader, and former ECE major who loves to understand how things work. - 4
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME - 5
Edita Rexha
Third-year student at the University of Prishtina
MPM Capital
Company attributes
Categories
Related Topics
Contributors
- 1
Khadidiatou Amirou
A knowledge enthusiast. - 2
Dawson Sewell
Seeking to explain science and technology through simple writing. - 3
Jordan Safer
Avid runner, book reader, and former ECE major who loves to understand how things work. - 4
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME - 5
Edita Rexha
Third-year student at the University of Prishtina